| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 9 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005783 | endoplasmic reticulum | 5 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043227 | membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HML7
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006508 | proteolysis | 4 | 1 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 1 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
| GO:0006950 | response to stress | 2 | 1 |
| GO:0008152 | metabolic process | 1 | 1 |
| GO:0009056 | catabolic process | 2 | 1 |
| GO:0009057 | macromolecule catabolic process | 4 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0010033 | response to organic substance | 3 | 1 |
| GO:0010243 | response to organonitrogen compound | 4 | 1 |
| GO:0010498 | proteasomal protein catabolic process | 5 | 1 |
| GO:0019538 | protein metabolic process | 3 | 1 |
| GO:0019941 | modification-dependent protein catabolic process | 6 | 1 |
| GO:0030163 | protein catabolic process | 4 | 1 |
| GO:0030433 | ubiquitin-dependent ERAD pathway | 6 | 1 |
| GO:0033554 | cellular response to stress | 3 | 1 |
| GO:0034976 | response to endoplasmic reticulum stress | 4 | 1 |
| GO:0036503 | ERAD pathway | 5 | 1 |
| GO:0042221 | response to chemical | 2 | 1 |
| GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 1 |
| GO:0043170 | macromolecule metabolic process | 3 | 1 |
| GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 1 |
| GO:0044237 | cellular metabolic process | 2 | 1 |
| GO:0044238 | primary metabolic process | 2 | 1 |
| GO:0044248 | cellular catabolic process | 3 | 1 |
| GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
| GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
| GO:0050896 | response to stimulus | 1 | 1 |
| GO:0051603 | proteolysis involved in protein catabolic process | 5 | 1 |
| GO:0051716 | cellular response to stimulus | 2 | 1 |
| GO:0071704 | organic substance metabolic process | 2 | 1 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
| GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
| GO:1901575 | organic substance catabolic process | 3 | 1 |
| GO:1901698 | response to nitrogen compound | 3 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005488 | binding | 1 | 1 |
| GO:0005515 | protein binding | 2 | 1 |
| GO:0032182 | ubiquitin-like protein binding | 3 | 1 |
| GO:0043130 | ubiquitin binding | 4 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 285 | 289 | PF00656 | 0.425 |
| CLV_C14_Caspase3-7 | 74 | 78 | PF00656 | 0.290 |
| CLV_NRD_NRD_1 | 170 | 172 | PF00675 | 0.480 |
| CLV_NRD_NRD_1 | 265 | 267 | PF00675 | 0.313 |
| CLV_NRD_NRD_1 | 330 | 332 | PF00675 | 0.526 |
| CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.449 |
| CLV_PCSK_KEX2_1 | 265 | 267 | PF00082 | 0.319 |
| CLV_PCSK_KEX2_1 | 330 | 332 | PF00082 | 0.526 |
| CLV_PCSK_KEX2_1 | 8 | 10 | PF00082 | 0.417 |
| CLV_PCSK_PC1ET2_1 | 25 | 27 | PF00082 | 0.554 |
| CLV_PCSK_PC1ET2_1 | 8 | 10 | PF00082 | 0.439 |
| CLV_PCSK_SKI1_1 | 163 | 167 | PF00082 | 0.512 |
| CLV_PCSK_SKI1_1 | 265 | 269 | PF00082 | 0.386 |
| CLV_PCSK_SKI1_1 | 296 | 300 | PF00082 | 0.414 |
| CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.447 |
| DEG_APCC_DBOX_1 | 162 | 170 | PF00400 | 0.559 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.474 |
| DOC_MAPK_gen_1 | 8 | 16 | PF00069 | 0.476 |
| DOC_MAPK_MEF2A_6 | 8 | 16 | PF00069 | 0.476 |
| DOC_PP2B_LxvP_1 | 12 | 15 | PF13499 | 0.500 |
| DOC_USP7_MATH_1 | 232 | 236 | PF00917 | 0.578 |
| DOC_USP7_UBL2_3 | 168 | 172 | PF12436 | 0.459 |
| DOC_USP7_UBL2_3 | 230 | 234 | PF12436 | 0.611 |
| DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.405 |
| LIG_14-3-3_CanoR_1 | 266 | 276 | PF00244 | 0.313 |
| LIG_14-3-3_CterR_2 | 330 | 332 | PF00244 | 0.515 |
| LIG_Actin_WH2_2 | 314 | 332 | PF00022 | 0.189 |
| LIG_APCC_ABBAyCdc20_2 | 234 | 240 | PF00400 | 0.642 |
| LIG_BIR_III_4 | 77 | 81 | PF00653 | 0.303 |
| LIG_BRCT_BRCA1_1 | 67 | 71 | PF00533 | 0.500 |
| LIG_deltaCOP1_diTrp_1 | 119 | 127 | PF00928 | 0.469 |
| LIG_deltaCOP1_diTrp_1 | 307 | 315 | PF00928 | 0.332 |
| LIG_EVH1_1 | 301 | 305 | PF00568 | 0.425 |
| LIG_FHA_1 | 100 | 106 | PF00498 | 0.469 |
| LIG_FHA_1 | 248 | 254 | PF00498 | 0.344 |
| LIG_FHA_1 | 275 | 281 | PF00498 | 0.423 |
| LIG_FHA_1 | 55 | 61 | PF00498 | 0.406 |
| LIG_FHA_2 | 18 | 24 | PF00498 | 0.439 |
| LIG_FHA_2 | 280 | 286 | PF00498 | 0.332 |
| LIG_LIR_Gen_1 | 31 | 42 | PF02991 | 0.473 |
| LIG_LIR_Nem_3 | 31 | 37 | PF02991 | 0.478 |
| LIG_NRBOX | 165 | 171 | PF00104 | 0.594 |
| LIG_Pex14_2 | 116 | 120 | PF04695 | 0.422 |
| LIG_Pex14_2 | 297 | 301 | PF04695 | 0.425 |
| LIG_SH2_SRC | 38 | 41 | PF00017 | 0.426 |
| LIG_SH2_STAP1 | 263 | 267 | PF00017 | 0.404 |
| LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.353 |
| LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.349 |
| LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.371 |
| LIG_SH3_3 | 252 | 258 | PF00018 | 0.400 |
| LIG_SH3_3 | 299 | 305 | PF00018 | 0.341 |
| LIG_SUMO_SIM_anti_2 | 57 | 68 | PF11976 | 0.491 |
| LIG_TRAF2_1 | 190 | 193 | PF00917 | 0.566 |
| LIG_TRAF2_1 | 20 | 23 | PF00917 | 0.476 |
| LIG_TRAF2_1 | 209 | 212 | PF00917 | 0.386 |
| LIG_TRAF2_1 | 217 | 220 | PF00917 | 0.569 |
| LIG_UBA3_1 | 165 | 172 | PF00899 | 0.556 |
| MOD_CK1_1 | 112 | 118 | PF00069 | 0.522 |
| MOD_CK2_1 | 153 | 159 | PF00069 | 0.513 |
| MOD_CK2_1 | 17 | 23 | PF00069 | 0.443 |
| MOD_CK2_1 | 279 | 285 | PF00069 | 0.393 |
| MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.586 |
| MOD_GlcNHglycan | 227 | 230 | PF01048 | 0.590 |
| MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.386 |
| MOD_GSK3_1 | 240 | 247 | PF00069 | 0.581 |
| MOD_GSK3_1 | 287 | 294 | PF00069 | 0.408 |
| MOD_NEK2_1 | 64 | 69 | PF00069 | 0.422 |
| MOD_NEK2_1 | 71 | 76 | PF00069 | 0.368 |
| MOD_PIKK_1 | 232 | 238 | PF00454 | 0.506 |
| MOD_PKA_2 | 112 | 118 | PF00069 | 0.481 |
| MOD_PKA_2 | 225 | 231 | PF00069 | 0.641 |
| MOD_Plk_1 | 290 | 296 | PF00069 | 0.425 |
| MOD_Plk_1 | 65 | 71 | PF00069 | 0.517 |
| MOD_Plk_4 | 274 | 280 | PF00069 | 0.332 |
| MOD_Plk_4 | 65 | 71 | PF00069 | 0.458 |
| MOD_Plk_4 | 78 | 84 | PF00069 | 0.366 |
| MOD_Plk_4 | 99 | 105 | PF00069 | 0.416 |
| MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.407 |
| MOD_SUMO_rev_2 | 312 | 321 | PF00179 | 0.370 |
| TRG_DiLeu_BaEn_1 | 59 | 64 | PF01217 | 0.448 |
| TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.369 |
| TRG_ER_diArg_1 | 265 | 267 | PF00400 | 0.313 |
| TRG_ER_diArg_1 | 329 | 331 | PF00400 | 0.386 |
| TRG_NES_CRM1_1 | 271 | 285 | PF08389 | 0.457 |
| TRG_Pf-PMV_PEXEL_1 | 216 | 220 | PF00026 | 0.603 |
| TRG_Pf-PMV_PEXEL_1 | 266 | 271 | PF00026 | 0.400 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HSJ2 | Leptomonas seymouri | 65% | 100% |
| A0A0S4JEV1 | Bodo saltans | 31% | 100% |
| A0A1X0P6W3 | Trypanosomatidae | 34% | 100% |
| A0A3R7KII9 | Trypanosoma rangeli | 34% | 100% |
| A0A3S7X998 | Leishmania donovani | 91% | 100% |
| A4IB95 | Leishmania infantum | 91% | 100% |
| C9ZZL9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
| E9AF19 | Leishmania major | 92% | 100% |
| E9B675 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
| Q28BP9 | Xenopus tropicalis | 24% | 75% |
| Q2HJD0 | Bos taurus | 25% | 75% |
| Q3TDN2 | Mus musculus | 28% | 75% |
| Q5BK32 | Rattus norvegicus | 27% | 96% |
| Q6AZH6 | Xenopus laevis | 22% | 75% |
| Q6GQ69 | Xenopus laevis | 25% | 75% |
| Q96CS3 | Homo sapiens | 28% | 75% |
| Q9M0N1 | Arabidopsis thaliana | 27% | 69% |